Yosipovitch, G; Lio, PA; Rosmarin, D; Casillas, M; Yang, FE; Hu, CR; Pierce, E; Legat, FJ; Carrascosa, JM; Crane, H; Boncompte, L; Stander, S.
497-Lebrikizumab in combination with topical corticosteroids maintains improvements in itch and sleep at 68 weeks in patients with moderate-to-severe atopic dermatitis
BRIT J DERMATOL. 2024; 190: II6-II7.
Doi: 10.1093/bjd/ljad498.008
[Poster]
Web of Science
FullText
FullText_MUG